Unlock stock picks and a broker-level newsfeed that powers Wall Street.
270.02
+1.56
+(0.58%)
At close: 4:00:01 PM EDT
271.07
+1.05
+(0.39%)
After hours: 7:06:04 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 17 | 16 |
| Avg. Estimate | -0.4 | -0.26 | 0.82 | 3.6 |
| Low Estimate | -0.93 | -1.32 | -2.06 | -0.54 |
| High Estimate | 0.51 | 0.93 | 4.39 | 14.41 |
| Year Ago EPS | -0.16 | 0.56 | -0.02 | 0.82 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 20 | 20 | 31 | 28 |
| Avg. Estimate | 584.31M | 629.81M | 2.88B | 3.65B |
| Low Estimate | 532M | 572.1M | 2.48B | 3.1B |
| High Estimate | 706.2M | 754.9M | 3.47B | 6.32B |
| Year Ago Sales | 494.33M | 659.83M | 2.25B | 2.88B |
| Sales Growth (year/est) | 18.20% | -4.55% | 28.05% | 26.91% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.63 | -0.69 | -0.39 | -0.14 |
| EPS Actual | -0.16 | 0.56 | -0.5 | 0.06 |
| Difference | 0.47 | 1.25 | -0.11 | 0.2 |
| Surprise % | 74.50% | 181.07% | -26.71% | 142.52% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.4 | -0.26 | 0.82 | 3.6 |
| 7 Days Ago | -0.4 | -0.26 | 0.83 | 3.58 |
| 30 Days Ago | -0.41 | -0.23 | 0.57 | 3.55 |
| 60 Days Ago | -0.53 | -0.5 | 0.66 | 5.45 |
| 90 Days Ago | -0.53 | -0.5 | 0.56 | 5.28 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | -- |
| Up Last 30 Days | 1 | 2 | 4 | 4 |
| Down Last 7 Days | 3 | 2 | 2 | 2 |
| Down Last 30 Days | 1 | -- | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALNY | -147.04% | -145.63% | 4,207.70% | 338.09% |
| S&P 500 | 16.20% | 6.69% | 10.00% | 14.33% |
Upgrades & Downgrades
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 3/31/2025 |
| Initiated | Redburn Atlantic: Buy | 3/31/2025 |
| Maintains | Stifel: Buy to Buy | 3/31/2025 |
| Upgrade | JP Morgan: Neutral to Overweight | 3/24/2025 |
| Maintains | Citigroup: Buy to Buy | 3/21/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 3/21/2025 |
Related Tickers
BBIO BridgeBio Pharma, Inc.
34.57
-1.54%
ARWR Arrowhead Pharmaceuticals, Inc.
12.74
-7.81%
IONS Ionis Pharmaceuticals, Inc.
30.17
-3.15%
SRPT Sarepta Therapeutics, Inc.
63.82
-9.36%
WVE Wave Life Sciences Ltd.
8.08
-6.26%
ARGX argenx SE
591.87
+0.46%
CYTK Cytokinetics, Incorporated
40.19
-6.95%
AXSM Axsome Therapeutics, Inc.
116.63
-1.60%
REGN Regeneron Pharmaceuticals, Inc.
634.23
-0.49%
MDGL Madrigal Pharmaceuticals, Inc.
331.23
+1.02%